about
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defectsRelation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research DatabaseRisk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice databaseMumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysisMMR vaccine and idiopathic thrombocytopaenic purpuraCurrent use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarctionUse of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarctionDiscontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarctionDrug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptomsAdverse reactions to methyldopa with particular reference to hypotensionAcute toxicity of aspirin in hospitalized medical patientsAdverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance ProgramUse of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarctionTamoxifen and risk of idiopathic venous thromboembolismClinical effects of meperidine in hospitalized medical patients.Comprehensive Drug SurveillanceThe incidence of breast cancer in the General Practice Research Database compared with national cancer registration dataPredictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.Using prescription claims data for drugs available over-the-counter (OTC).Drug-induced blood disorders.A follow-up safety study of ciprofloxacin users.Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study.Hospitalization for serious blood and skin disorders following use of co-trimoxazole.Hospitalization for serious blood and skin disorders following co-trimoxazoleValidation of information recorded on general practitioner based computerised data resource in the United Kingdom.Acute adverse reactions attributed to allopurinol in hospitalised patientsAntibiotic-associated colitisIncidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.ON THE RENAL SITE AND MODE OF ACTION OF GLUCOCORTICOID IN CIRRHOSISRecombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.Drug rash with ampicillin and other penicillins.Estrogens, progesterone, and endometrial cancer.Incidence and prevalence of drug-treated attention deficit disorder among boys in the UKAntidepressants and the risk of suicidal behaviors.Adverse reactions to procainamideStatins and the risk of dementia.Rate of suicide in patients taking montelukast.Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity.
P50
Q22337418-455D2D8C-B9B3-411A-AAED-B2AAC8475F4AQ24530178-018A680E-FC6A-42C7-A65C-2892BF4B1C86Q24609638-CEDDA2D6-A381-47CC-BD5C-70FD46CA09EEQ24657629-7BDD88E4-6AA8-4DD5-B943-7C585704A811Q24679503-2DF79E2B-1463-476F-9536-BA65145A4BE8Q28181807-411318EB-68CC-45D9-B3AC-273CF1EF1A96Q28193777-9FFB332B-2C81-4CEF-B88E-89A437FE4E6AQ28211707-12CE20EC-894F-44A2-BA16-8964CFC1F8E2Q28318050-75B512D5-538A-4EA8-95AF-59834F799F32Q28323587-5AB4096A-40DC-4035-872D-166698598128Q28323941-07D6178C-B347-44AD-BB14-6D73D44E7506Q28324227-EDCCC509-745E-4A79-ACEB-83B4EBEFBE16Q28345555-1B8F443B-EDD7-4C3D-AF61-D682E76F3351Q28368257-60054837-96D3-4025-801C-A466163FD67BQ30241202-93BE4C08-575F-4A98-B3B1-52CB81ACF973Q30241219-FED665CA-0510-4C18-89BE-B8DAF65135BAQ30619761-EF002DFC-F7EE-4ADA-9B6F-94F1E5840235Q30805224-069C2684-689D-49A9-980A-6C8CE1EC1352Q30992334-86F42732-62B8-41EA-88C4-8F8016AEA092Q31119847-11435718-2A4B-4E6A-9ECC-A32294C9F6CAQ33475829-7AED5B72-625C-4DBF-8568-2C9EEBBFA795Q33493169-BDF73B81-F27F-4CA0-AC94-F11B28BB95F6Q33493634-EFE6EF78-F9E6-443C-AB5F-DC6C8D4FA674Q33499238-45333683-BB01-4E49-A9DD-92A9E7978209Q33499676-EC0C070B-75B3-4495-A62A-489CD8796637Q33539292-CDCF22D9-9820-4E68-9491-A71FEDC1F7E9Q33553124-378C4E19-F907-4384-9889-9297195A7878Q33605790-8D8504A5-615B-4B02-8A82-A158816C5896Q33799389-F6C0B44C-F234-41C4-97AA-558A42EB7903Q33949895-0B3494FF-732B-499F-82E4-44172B81AF3CQ33981365-44CF385F-CD4A-486C-8C2D-C1227E390C3BQ34051778-ADDD03DB-7F6C-4AFC-A3DB-26FA17DFE7ECQ34061512-111DAFB0-B57B-4E47-B64F-EEA26F8D5FB5Q34098764-F0E7DC4E-000E-4663-A76C-9D39B8649342Q34334805-B7754A7B-2A35-4432-B1D9-8C3D3AA100CAQ34422904-09DEEDE4-CD30-4B5F-ADB8-F54E1BCE7096Q34511970-114AF07A-86FF-4328-BF31-0EA19DE2E405Q34603635-A09FF6C0-A9F8-4298-A298-84D001273674Q34640746-5874184F-1368-40E9-B9AA-E87FA1C33D9DQ34662279-9C2D5F1A-B4E1-4281-B9D9-B6E0BF585E21
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hershel Jick
@ast
Hershel Jick
@en
Hershel Jick
@es
Hershel Jick
@nl
Hershel Jick
@sl
type
label
Hershel Jick
@ast
Hershel Jick
@en
Hershel Jick
@es
Hershel Jick
@nl
Hershel Jick
@sl
prefLabel
Hershel Jick
@ast
Hershel Jick
@en
Hershel Jick
@es
Hershel Jick
@nl
Hershel Jick
@sl
P106
P31
P496
0000-0003-4270-5992